<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/css/uswds.min.css">
    <link rel="stylesheet" href="/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/21CFR1271.html">Part 1271
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 1271.10  Are my HCT/P's regulated solely under section 361 of 
I do?
                            </h3>
                            <p class="depth0"><em>(a)</em> An HCT/P is regulated solely under section 361 of the PHS Act and the regulations in this part if it meets all of the following criteria:</p><p class="depth0"><em>(1)</em> The HCT/P is minimally manipulated;</p><p class="depth0"><em>(2)</em> The HCT/P is intended for homologous use only, as reflected by the labeling, advertising, or other indications of the manufacturer's objective intent;</p><p class="depth0"><em>(3)</em> The manufacture of the HCT/P does not involve the combination of the cells or tissues with another article, except for water, crystalloids, or a sterilizing, preserving, or storage agent, provided that the addition of water, crystalloids, or the sterilizing, preserving, or storage agent does not raise new clinical safety concerns with respect to the HCT/P; and</p><p class="depth0"><em>(4)</em> Either:</p><p class="depth0"><em>(i)</em> The HCT/P does not have a systemic effect and is not dependent upon the metabolic activity of living cells for its primary function; or</p><p class="depth0"><em>(ii)</em> The HCT/P has a systemic effect or is dependent upon the metabolic activity of living cells for its primary function, and:</p><p class="depth0"><em>(a)</em> Is for autologous use;</p><p class="depth0"><em>(b)</em> Is for allogeneic use in a first-degree or second-degree blood relative; or</p><p class="depth0"><em>(c)</em> Is for reproductive use.</p><p class="depth0"><em>(b)</em> If you are a domestic or foreign establishment that manufactures an HCT/P described in paragraph (a) of this section:</p><p class="depth0"><em>(1)</em> You must register with FDA;</p><p class="depth0"><em>(2)</em> You must submit to FDA a list of each HCT/P manufactured; and</p><p class="depth0"><em>(3)</em> You must comply with the other requirements contained in this part.
[66 FR 5466, Jan. 19, 2001, as amended at 69 FR 68681, Nov. 24, 2004]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
